Extra-Enzymatic Roles of DPIV and FAP in Cell Adhesion and Migration on Collagen and Fibronectin

  • Xin M. Wang
  • Denise M. T. Yu
  • Geoffrey W. McCaughan
  • Mark D. Gorrell
Part of the Advances in Experimental Medicine and Biology book series (volume 575)

5. Conclusions

FAP and DPIV overexpression in the HEK293 cell line reduced cell adhesion, migration and invasion on ECM components, increased proliferation and promoted apoptosis, independently of enzyme activity. These observations may aid an understanding of the roles of FAP and DPIV in tissue remodeling.


Green Fluorescent Protein 293T Cell Dipeptidyl Peptidase Discoidin Domain Receptor Fibroblast Activation Protein 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abbott CA, McCaughan GW, Gorrell MD, 1999, Two highly conserved glutamic acid residues in the predicted beta propeller domain of dipeptidyl peptidase IV are required for its enzyme activity. FEBS Lett. 458: 278–284.CrossRefPubMedGoogle Scholar
  2. Aertgeerts K, Levin I, Shi L, Snell GP, Jennings A, Prasad GS, Zhang Y, Kraus ML, Salakian S, Sridhar V, Wijnands R, Tennant MG, 2005, Structural and kinetic analysis of the substrate specificity of human fibroblast activation protein. J Biol. 280: 19441–41944.CrossRefGoogle Scholar
  3. Ajami K, Abbott CA, Obradovic M, Gysbers V, Kähne T, McCaughan GW, Gorrell MD, 2003, Structural requirements for catalysis, expression and dimerisation in the CD26/DPIV gene family. Biochemistry. 42: 694–701.CrossRefPubMedGoogle Scholar
  4. Ajami K, Abbott CA, McCaughan GW, Gorrell MD, 2004, Dipeptidyl peptidase 9 is cytoplasmic and has two forms, a broad tissue distribution, cytoplasmic localization and DPIV—like peptidase activity. BBA—Gene Struct Expression. 1679: 18–28.CrossRefGoogle Scholar
  5. Alahari SK, Lee JW, Juliano RL, 2000, Nischarin, a novel protein that interacts with the integrin alpha5 subunit and inhibits cell migration. J Cell Biol. 151: 1141–1154.CrossRefPubMedGoogle Scholar
  6. Aldinucci D, Poletto D, Lorenzon D, Nanni P, Degan M, Olivo K, Rapana B, Pinto A, Gattei V, 2004, CD26 expression correlates with a reduced sensitivity to 2′-deoxycoformycin-induced growth inhibition and apoptosis in T-cell leukemia/lymphomas. Clin Cancer Res. 10: 508–520.CrossRefPubMedGoogle Scholar
  7. Cheng HC, Abdel-Ghany M, Pauli BU, 2003, A novel consensus motif in fibronectin mediates dipeptidyl peptidase IV adhesion and metastasis. J Biol Chem. 278: 24600–24607.CrossRefPubMedGoogle Scholar
  8. Hanski C, Huhle T, Reutter W, 1985, Involvement of plasma membrane dipeptidyl peptidase IV in fibronectin-mediated adhesion of cells on collagen. Biol Chem Hoppe Seyler. 366: 1169–1176.PubMedGoogle Scholar
  9. Kajiyama H, Kikkawa F, Khin E, Shibata K, Ino K, Mizutani S, 2003, Dipeptidyl peptidase IV overexpression induces up-regulation of E-cadherin and tissue inhibitors of matrix metalloproteinases, resulting in decreased invasive potential in ovarian carcinoma cells. Cancer Res. 63: 2278–2283.PubMedGoogle Scholar
  10. Levy MT, McCaughan GW, Abbott CA, Park JE, Cunningham AM, Rettig WJ, Gorrell MD, 1999, Fibroblast activation protein: A cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis. Hepatology. 29: 1768–1778.CrossRefPubMedGoogle Scholar
  11. Levy MT, McCaughan GW, Marinos G, Gorrell MD, 2002, Intrahepatic expression of the hepatic stellate cell marker fibroblast activation protein correlates with the degree of fibrosis in hepatitis C virus infection. Liver. 22: 93–101.CrossRefPubMedGoogle Scholar
  12. Luo J, Lubaroff DM, Hendrix MJ, 1999, Suppression of prostate cancer invasive potential and matrix metalloproteinase activity by E-cadherin transfection. Cancer Res. 59: 3552–3556.PubMedGoogle Scholar
  13. Matsumoto Y, Bishop GA, McCaughan GW, 1992, Altered zonal expression of the CD26 antigen in human cirrhotic liver. Hepatology. 15: 1048–1053.PubMedGoogle Scholar
  14. Matsuyama W, Wang L, Farrar WL, Faure M, Yoshimura T, 2004, Activation of discoidin domain receptor 1 isoform b with collagen up-regulates chemokine production in human macrophages: role of p38 mitogen-activated protein kinase and NF-kappa B. J Immunol. 172: 2332–2340.PubMedGoogle Scholar
  15. Mizokami Y, Kajiyama H, Shibata K, Ino K, Kikkawa F, Mizutani S, 2004, Stromal cell-derived factor-1alphainduced cell proliferation and its possible regulation by dipeptidyl peptidase IV in endometrial adenocarcinoma. Int J Cancer. 110: 652–659.CrossRefPubMedGoogle Scholar
  16. Mueller SC, Ghersi G, Akiyama SK, Sang QXA, Howard L, Pineiro-Sanchez M, Nakahara H, Yeh Y, Chen WT, 1999, A novel protease-docking function of integrin at invadopodia. J Biol Chem. 274: 24947–24952.CrossRefPubMedGoogle Scholar
  17. Park JE, Lenter MC, Zimmermann RN, Garin-Chesa P, Old LJ, Rettig WJ, 1999, Fibroblast activation protein: A dual-specificity serine protease expressed in reactive human tumor stromal fibroblasts. J Biol Chem. 274: 36505–36512.CrossRefPubMedGoogle Scholar
  18. Pethiyagoda CL, Welch DR, Fleming TP, 2001, Dipeptidyl peptidase IV (DPPIV) inhibits cellular invasion of melanoma cells. Clin Exp Metastasis. 18: 391–400.CrossRefGoogle Scholar
  19. Ramirez-Montagut T, Blachere NE, Sviderskaya EV, Bennett DC, Rettig WJ, Garin-Chesa P, Houghton AN, 2004, FAPalpha, a surface peptidase expressed during wound healing, is a tumor suppressor. Oncogene. 23: 5435–5446.CrossRefPubMedGoogle Scholar
  20. Sato K, Aytac U, Yamochi T, Ohnuma K, McKee KS, Morimoto C, Dang NH, 2003, CD26 enhances expression of topoisomerase II alpha and sensitivity to apoptosis induced by topoisomerase II inhibitors. Br J Cancer. 89: 1366–1374.CrossRefPubMedGoogle Scholar
  21. Shackel NA, McGuinness PH, Abbott CA, Gorrell MD, McCaughan GW, 2002, Insights into the pathobiology of hepatitis C virus associated cirrhosis: Analysis of intrahepatic differential gene expression. Am J Pathol. 160: 641–654.PubMedGoogle Scholar
  22. Slimane TA, Lenoir C, Bello V, Delaunay JL, Goding JW, Chwetzoff S, Maurice M, Fransen JAM, Trugnan G, 2001, The cytoplasmic/transmembrane domain of dipeptidyl peptidase IV, a type II glycoprotein, contains an apical targeting signal that does not specifically interact with lipid rafts. Exp Cell Res. 270: 45–55.CrossRefPubMedGoogle Scholar
  23. Wesley UV, Albino A, Tiwari S, Houghton A, 1999, A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells. J Exp Med. 190: 311–322.CrossRefPubMedGoogle Scholar
  24. Wesley UV, Tiwari S, Houghton AN, 2004, Role for dipeptidyl peptidase IV in tumor suppression of human non small cell lung carcinoma cells. Int J Cancer. 109: 855–866.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2006

Authors and Affiliations

  • Xin M. Wang
    • 1
  • Denise M. T. Yu
    • 1
  • Geoffrey W. McCaughan
    • 1
  • Mark D. Gorrell
    • 1
  1. 1.A. W. Morrow Gastroenterology and Liver Centre at Royal Prince Alfred HospitalCentenary Institute of Cancer Medicine and Cell Biology and the University of Sydney Discipline of MedicineSydneyAustralia

Personalised recommendations